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ABSTRACT 
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a 
pathogen that has historically been identified in hospital-acquired infections 
since the mid 1900's. Epidemiologically significant trends have occurred which 
have identified the increasing prevalence of MRSA in the community setting. 
Methods: An investigation of all isolates positive for Staphylococcus aureus of 
the inpatient population was conducted over a nine year time period in a 
university teaching hospital. Additionally, a unit specific case/control study was 
conducted during an outbreak of MRSA in a neonatal intensive care unit. 
Results: From January of 1997 through December of 2005, the number of 
isolates identified as positive for S. aureus had increased. Additionally, the 
proportion of MRSA to Methicillin-sensitive Staphylococcus aureus (MSSA) had 
increased from 40 to 60%. A chi-square test was conducted comparing the 
number of isolates positive for MRSA in 1997 versus 2005 which was found to 
be statistically significant with a P value < 0. 001. 
Additionally, from January 1997 through December 31, 2001, the first 
greatest change in proportion of MRSA to MSSA was noted. The increase in 
isolates identified as positive for MRSA was found to be approximately three 
times as great. The comparison of isolates identified as MRSA in 1997 versus 
2001 was statistically significant with a P value <0.001. 
A hospital-acquired case is defined as one in which the specimen positive 
for MSSA or MRSA was obtained 48 hours after admission to the hospital. 
Conversely, a community-acquired case is defined as having a culture positive 
for MSSA or MRSA obtained within 48 hours of admission. Using a chi-square 
test we found no statistically significant difference in identification of the 
acquisition of MSSA or MRSA as to whether the patients were adrnitted from 
home or another health care institution. The number of community-acquired 
cases identified as positive for MRSA was higher than those that were hospital- 
acquired. 
Lastly, through a case/control study of infants leading to NlCU employee 
screening for identification of employees for positive colonization status with 
MRSA, we identified the common source who served as a reservoir for 
transmission of this pathogen. 
Conclusion: Methicillin-resistant Staphylococcus aureus has emerged as a 
significant public health burden and serves as a warning requiring the attention 
of key stakeholders to implement rigorous actions to control the spread and 
reduce the development of multi-drug resistant organisms. 
I. INTRODUCTION 
Background of Problem 
During the time period of January 01, 1997 through December 31,2005, 
the Department of Epidemiology observed what was suspected to be an 
increasing endemic rate of infections positive for methicillin-resistant 
Staphylococcus aureus (MRSA) at Hospital A. 
An investigation was conducted to determine if we were actually seeing a 
significant increase in the number of infections positive for Staphylococcal aureus 
(S. aureus), in which 2001 appeared to be the pivotal year during which the 
numbers increased at a greater rate. Additionally, it would be important to 
determine if the proportion of MRSA to methicillin-sensitive S. aureus (MSSA) 
remained stable or if we were observing an increase in prevalence of one of the 
two organism subtypes. Lastly, of significant importance was to determine 
whether or not Hospital A was experiencing a change in the epidemiology of S. 
aureus. This would include identifying whether or not these cases that were 
positive for infections or colonization with S. aureus were determined to be 
comn~unity or hospital-acquired. 
During the time period of January 1,2001 through December 31,2001, we 
noted that there was a significant increase in the nurr~ber of isolates which were 
determined by the microbiology laboratory to be positive for MRSA. Because of 
the increasing number of this clinically important, antibiotic-resistant pathogen, 
we conducted an investigation to determine the epidemiologic characteristics of 
patients infected with MSSA and MRSA in Hospital A over a one-year period. It 
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was our goal to determine if the proportion of MRSA isolates had increased in 
relation to MSSA, or if we were beginning to see an increase in the prevalence of 
both organisms. Additionally, we were interested to determine if patients with 
specific characteristics such as age or gender were predisposed to acquire an 
infection positive for S. aureus identified as methicillin resistant or methicillin 
sensitive. 
Lastly, to illustrate the potential magnitude of harm to patients and impact 
on the health system caused by infections with this pathogen, we also conducted 
an in-depth description of a hospital-based inpatient investigation. The study 
was an investigation of a cluster of cases positive for MRSA which were 
identified during routine surveillance in the neonatal population. 
For the purpose of this thesis, I applied to the University of Connecticut 
Health Center's Institutional Review Board and was granted approval to conduct 
certain aspects of surveillance and investigation for this project (IRB Protocol 
number 05-01 9). 
This overview will identify three goals of the S. aureus investigations that 
were conducted: 
To identify if there had been an increase in the prevalence of 
patients identified as having a culture positive for S. aureus. 
To determine any changes in the proportion of cultures positive for 
MSSA versus MRSA of the total number of cultures identified as 
positive for S. aureus. 
To identify of the inpatient population admitted to Hospital A during 
this time period, any epidemiologically significant change in trend 
between the relationship of the nurr~ber of community-acquired 
versus hospital-acquired infections positive for S. aureus. 
Definitions of Staphylococcus aureus: Physical Status 
In discussing the physical status of a person who has acquired an 
organism, one must first determine the level of activity the potential pathogen is 
exhibiting in the person's body. This activity, caused by mere existence or 
proliferation of the organism, may impact one's health, causing serious illness 
and, in extreme circumstances, death. 
Determining the level of activity of the organism may also help us 
understand the infection control practices of importance that will prevent the 
active or passive transmission of this organism from one person to another. 
A person may have one of four levels of physical response after a 
potential or actual exposure to an organism. The level is a negative 
response in which the person may or may not have had a significant exposure to 
an orgar~ism but, because of many different potential actions or non-actions, 
there were no consequences. For example, the person may have touched 
something contaminated with the organism, but did not touch his or her mouth, 
nose or eyes and adhered to good hand hygiene, therefore eliminating the risk of 
exposure. 
The second level of status is colonization. The person has had a 
significant exposure to an organism, may or may not have attempted to conduct 
adequate preventative measures and was unable to prevent the acquisition of 
the organism. The person may have presence of this organism externally or in 
non-sterile sites (i.e., their nares [inside the nose] or in tissue), but it remains 
indolent (i.e., not multiplying). The person does not exhibit signs or symptoms of 
illness and is generally not infectious, although there has been evidence that the 
organism potentially can be transmitted to another person by exposure to body 
substance material from the colonized person (e.g., the colonized person wipes 
his or her nose or sneezes into the hands and does not wash the hands). The 
colonized person has contaminated his or her hands and proceeds to make 
contact with the non-colonized person by engagirlg in shaking hands. The non- 
colonized person potentially has now contaminated his or her own hand with this 
organism and could become inoculated by introducing it into histher own body by 
touching the mouth or nose. As discussed by Siegel, Rhinehart, Jackson, 
Chiarello, and the Healthcare Infection Control Practices Advisory Committee 
(2007), there are basic activities that could prevent transmission and self- 
inoculation, such as covering your mouth and nose by coughing or sneezing into 
your sleeve and following good hand hygiene practices. 
The third level of physical status related to exposure to an organism is 
clinical infection. If this organism was introduced into a sterile body site or an 
opening in the skin such as blood or a wound, the chances of developing a more 
severe infection increases and the person would exhibit signs and symptoms of 
illness. The person has been exposed to an organism which has been 
introduced into the body in one of several routes. These may include 
introduction through the mucous membrane; through the impaired integrity in the 
integumentary system, such as the skin; or ,through a breach in a sterile body 
site. Introduction into a sterile body site may occur as an unintended 
consequence of an invasive procedure. Regardless of the specific route, once 
the organism is allowed to enter the body it proliferates, causing the development 
of a localized infection, soft tissue abscess, or a more serious systemic infection. 
The person would exhibit any or all symptoms of illness such as fever, pain and 
swelling, and the condition would require medical intervention. 
The fourth level of exposure is of a person who had been infected with the 
organism and received treatment resulting in either eradication of the organism 
(negative status) or a stable, colonized status. See Table 1 below. 
Negative 
Colonized 
No 
l nfected 
1 negative status achieved 1 1 I I 
Yes 
Infected and treated and 1 No 
No 
Yes ( Yes 
No 
No 
Yes 
No 
l nfected and treated and 
patient remains colonized 
Unlikely through 
casual contact 
No 
Yes No Unlikely through 
casual contact 
Methods of Determining Patient's Physical Status of Staphylococcus 
aureus 
The methods used to determine the patient's status in the studies 
presented include surveillance data from many sources within the hospital. 
Among these sources, the most frequently accessed are described in the 
following paragraphs. 
It is not routine practice at this time to conduct bacterial surveillance 
cultures on all patients admitted to the hospital or standard practice to screen all 
patients for MSSA or MRSA. Specimens collected on inpatients are sent to the 
laboratory if ordered by the physician to aid in determining medical diagnosis. 
The studies explained in the context of this paper only include those patients who 
had microbiology laboratory tests ordered by ,their physician which were obtained 
and processed and which concluded in the positive identification of S. aureus. If 
culture results were negative for S. aureus the patient was not included in the 
study. 
Microbiology laboratory reports of isolates positive for S. aureus were 
investigated from January I, 1997 to December 31, 2005 in order to analyze 
trends in incidence, prevalence and emerging patterns of antimicrobial resistance 
to antibiotics. The documented minutes from the Infection Control Committee 
which are generated monthly from this time period and the line listing of cases 
positive for MRSA which were compiled over the previous nine years were 
reviewed. The cases that were included were those determined to have clinical 
infections with MRSA that were identified as either hospital-acquired or 
community-acquired. 
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In addition to the nine-year review, an in depth epidemiologic analysis was 
conducted on all isolates identified as positive for S. aureus in the Hospital A 
Clinical Microbiology Laboratory from a single year: January 1, 2001 to 
December 31, 2001. This analysis was conducted in order to identify the 
association with MSSA and MRSA positive isolates and to better characterize the 
risk factors of patients potentially predisposed to developing these infections. 
This was accomplished by review of the patients' medical records to determine 
the physical status of the patient regarding colonization or infection. 
Finally, an epidemiologic investigation was undertaken involving a cluster 
of cases positive for MRSA colonization and infection that were identified during 
the course of conducting routine field surveillance during the time period of 2000- 
2001. 
The specific methodology unique to each project is described in the 
sections that review the overall investigations that were conducted. 
Pathogen 
Staphyloccocus aureus (S. aureus) is an organism that has historically 
been identified as a pathogen responsible for causing a wide variety of infections 
in hospitals, primarily involving the urinary tract, abdominal wounds, pneumonia 
and blood stream infections. In the 1940's and 1 9 5 0 ' ~ ~  virtually all infections 
involving S. aureus were susceptible to all P - lactam drugs, including penicillin 
and cephalosporins. However, naturally occurring resistance to P - lactam 
drugs, such as penicillin, began to increase in the 1960's and is widespread 
today (Stapleton & Taylor, 2002). 
Microbial resistance to antibiotics occurs in bacteria and other organisms 
in different ways. The development of resistance can occur with gene mutations 
i.e., from antibiotic pressure as a natural development of the bacteria or random 
changes in DNA (Wikipedia, 201 0). Antibiotic resistant DNA may either be 
transferred to, or acquired by staphylococci from other bacteria in the species via 
usual bacterial horizontal transference. The transfer or acquisition of mutated 
DNA occurs more frequently than individual bacterium developing DNA mutation 
on their own. Once mutated DNA is acquired, resistance is caused by the DNA 
in several potential ways. One method of resistance occurs when the bacteria 
acquires mutations that enable it to evade the activity of the antibiotics by 
secreting an enzyme that inactivates the antibiotic. Another method is the 
development of the ability to either pump the antibiotic out of the cell or prevent 
the antibiotic from binding to the cell wall through the action of penicillin-binding 
proteins (National Institutes of Health, 2006; Ito, Katayama, & Hiramatsu, 1999; 
W. Hryniewicz, 1999). Because of their proliferative nature, bacteria, which are 
single cell organisms, have the capability of increasing the enormity of the 
problem of antimicrobial resistance at an alarming rate. 
Increasing prevalence of antibiotic resistance began to emerge in isolates 
from hospitals during the 1950's and 1960's. The occurrence of resistance 
emerged soon after the development and widespread use of P - lactam 
antibiotics, such as penicillin, to treat infections during the wake of World War II. 
The initial response toward the resolution of this significant public health issue 
was to develop new; semi-synthetic antibiotics similar in structure and action to 
penicillin to treat infections demonstrating resistance to penicillin. In turn, wide- 
spread use of these new drugs, such as oxacillin and methicillin, resulted in 
increasing resistance to the semi-synthetic antibiotics (Sack, 2007). The pattern 
of the development of resistance was observed by Klein, Smith, & Laxminarayan 
(2007). They described the process of resistance to newer, synthetic antibiotics 
as mimicking the "wave-like" development of resistance that was seen with 
penicillin. This wave-like pattern refers to the initial identification of a low 
incidence of infections with organisms that had developed resistance and the 
subsequent recurring rise or prevalence in numbers of infections identified in 
which many patients were affected. 
During the 1960's and over the next three decades, resistant infections 
continued to be limited to hospitals where MRSA was identified primarily as 
infecting very ill inpatients with complicated medical and surgical histories. 
Infections with MRSA were attributed to the hospital setting because it was 
believed that the development of resistance was a product of antibiotic pressure. 
Antibiotic pressure is defined by the Alliance for the Prudent Use of Antibiotics 
(2010), as the natural selection of some bacterium to survive and multiply in the 
presence of certain potential barriers such as antibiotics. 
These infections were usually serious blood stream infections, pneumonia, 
surgical site infections, abdominal wounds and heart valve infections. They were 
associated with high morbidity and mortality and were responsible for increasing 
length of hospital stay and costs of care. 
During the early 1990Js, MRSA, for the most part, remained confined to 
the institutional setting. However, as we entered into the late 1990's and early 
2000's there was a dramatic shift in the epidemiology of this pathogen. During 
'this time, the first wave of community-acquired cases of MRSA were identified in 
patients who were not previously hospitalized and did not have a history of living 
in an extended care facility or short term rehabilitation center. 
The significance of the increased incidence of infections positive for 
community-acquired MRSA was demonstrated in a study by Kuehnert, Hill, 
Kupronis, Tokars, Solomon, & Jernigan (2005). The study looked at discharges 
from United States hospitals during the time period of 1999 through 2000. The 
investigators used the International Statistical Classification of Diseases and 
Related Health Problems ("ICD 9") codes to determine that almost 130,000 
patients over this time period were hospitalized from the community with 
infections caused by MRSA. These observations illustrated that community- 
acquired MRSA had emerged as a significant public health burden. In another 
study by Kuehnert, et al (2006), the prevalence of nasal colonization rates of 
MSSA in the general population was studied. The investigators tested the nares 
of 9,622 people as part of the National Health and Nutrition Examination Survey 
and found that 3,079 (32%) of the total number tested were colonized with MSSA 
and 77 (0.8%) were colonized with MRSA. They concluded that while the overall 
rate of colonization with MRSA in 2001-2002 appears low in comparison with 
MSSA, the rate might vary depending upon demographics, specific virulence 
factors with this organism and host risk factors, including prior exposure to 
antibiotics. The influence of these factors could indicate that those people living 
in a different demographic area or specific living environment such as physically 
close living arrangements may be predisposed to the development of 
colorrization with MRSA at a higher rate compared to MSSA. 
The emergence of comm~~nity-acquired MRSA infections had rapidly 
become a significant public health threat over the past decade. Infections 
diagnosed in the community typically differ in comparison to those that are 
considered hospital-acquired. Community-acquired infections are usually 
identified as occurring in different anatomical sites and also differ in what 
antibiotics are niost effective for treatment. These infections typically involve skin 
and soft tissue with the development of abscesses and pustules and are most 
successfully treated with clindamycin or bactrim. The majority of these infections 
can be treated in the outpatient setting. However, some are serious and may 
even be life threater~i~ig and require admission to an acute care facility for 
treatment with intravenous antibiotics and in extreme cases life support. 
Fridkin, et al. (2005) studied the prevalence of MRSA infections in three 
communities and identified the most frequently infected physical site. The group 
identified 1,647 patients with isolates positive for MRSA from the three 
communities during the time period of 2001 through 2002. Of these isolates 
positive for MRSA, they determined that between 8 and 20 percent of all 
laboratory isolates tested from patients in these communities were positive for 
MRSA and were identified as corr~murrity-acquired. Of the total number of 
community-acquired infections positive for MRSA, ,the majority, or 1,270 (77%), 
involved skin and soft tissue. One fourth of these infections progressively 
developed into infections requiring admission to a hospital for treatment. 
One issue influencing the impact of infections positive for community- 
acquired MRSA on public health is the lack of farr~iliarity with the emergence of 
these community-acquired infections. The lack of knowledge of the Licensed 
Independent Practitioners in the community and private offices inhibits the timely 
diagnosis and swift initiation of appropriate antibiotic treatment. To facilitate 
appropriate treatment these practitioriers need education on the characteristics of 
the infections, typical progression of the infection process and appropriate 
antibiotic treatment. This knowledge deficit in the outpatient setting has led to 
cases being largely misdiagnosed and, therefore, ineffectively treated. For 
instance, as has been observed by Tom Frank, Pharm. D., B.C.P.S., an 
associate professor of pharmacy practice and assistant professor of farr~ily and 
commurrity medicine (Peck, 2004) and Dr. Tamara Dominguez (2004), some 
infections positive for MRSA were treated as spider bites. These infections 
involving soft tissue, resembling spider bites, were treated as such even when 
occurring in geographical areas not commonly known to be inhabited by spiders. 
Consequently, these infections progressed to deep, intrusive, multi-layered 
abscesses which were serious and difficult to treat. If mistreated, community- 
acquired MRSA infections can be very aggressive, involving multiple organ 
systems and even death. An example of this lack of awareness was reported in 
a news article by Manning (2006). The article described the case of a 14-month- 
old male who had been brought to the pediatrician's office for assessment and 
was diagnosed with a common cold. Over the following week the child's 
condition continued to progressively worsen. Eventually his health status 
plummeted and he was diagnosed with necrotizing (death of tissue) pneumonia 
caused by MRSA. The child recovered after a complicated 55-day 
hospitalization including intensive care and support by mechanical ventilation. 
The review of literature has demonstrated an increasing prevalence of 
antibiotic resistant infections positive for S. aureus over time. The changing 
epidemiology of MRSA from being primarily a hospital-acquired pathogen to 
community-acquired has been well documented over the past decade. The 
impact and significance of these infections on public health, both real and 
perceived, have changed the usual and customary way hospitals and 
communities have responded to infections. A thorough investigation and 
analysis of S. aureus isolates and cases of infection in Hospital A has proven to 
reflect accurately on the changing trends in epidemiology as documented in the 
literature. This report will validate the similarities of these study findings and 
demonstrate the tremendous impact that these infections have on the health- 
care system at this university teaching hospital. 
It has become paramount and essential that we, as responsible healthcare 
providers and public health agents, understand the changing epidemiology of 
these pathogens and continue to develop effective strategies to treat our patients 
therapeutically and appropriately in a timely manner and prevent further 
transmission of this life-threatening pathogen. 
II Methods 
The following describes the methods used in both Section I and II. The 
Microbiology lab responds to the identification of Staphylococcus species in all 
clinical samples. They do this by the technique described in the following 
paragraph. 
Inpatient specimens are processed ,through the hospital's microbiology 
laboratory. All specimens sent to the laboratory for bacteriological culture are 
inoculated onto various kinds of solid plated media. Specimens resultirlg in a 
positive culture undergo a gram stain process for further identification. Once a 
bacterial colony is identified as gram positive cocci (in clusters or groups), the 
sample then undergoes a latex agglutination test called Staphaurex. If the 
organism is identified as being coagulase positive, that is, causing clumping of 
the Staphaurex latex reagent, it is Staphylococcus aureus. Further testing for the 
minimum inhibitory concentration (MIC) is deterrr~ined by inoculating an MIC 
panel of different antibiotic concentrations with the organism. The lowest 
concentration of antibiotic that inhibits the organism from growing is the MIC. 
Additionally, in the case of oxacillin resistant Staphylococcus, such as MRSA, the 
organism may also be plated onto an oxacillin screening agar to confirm oxacillin 
resistance. To identify those patients who had isolates which were positive for 
MSSA or MRSA, a retrospective review of all cultures positive for S. aureus was 
conducted for the specified time period of each investigation. The patients who 
were included in the study were identified through a microbiology laboratory 
query. They included those who had a culture from any body source positive for 
MSSA andlor MRSA. 
Only the first positive MSSA or MRSA isolate obtained from the patient 
was used for the working diagnosis. The nature of these investigations involved 
the use of medical records and laboratory results of the inpatient population at 
Hospital A. 
Upon identifying the patients with cultures positive for MSSA or MRSA 
during the stated time period, a chart review was conducted to access medical 
information including patient history through the Health Information Systems 
Department. The purpose of the chart review was to determine if the patient was 
infected or colonized with the identified organism. The criterion to determine the 
physical status of a patient who had acquired S. aureus colonization or infection 
includes: i) an isolate positive for S. aureus, and ii) physician documentation of 
diagnosis of infection. The diagnosis may or may not have been supported by 
additional criteria such as: identification of symptoms, antibiotic treatment or 
illness indicative of infection such as fever, pneumonia or bactererr~ia. 
Once a patient is identified as having an infection positive for S. aureus; 
we defined the acquisition date of the samples that grew the S. aureus isolate as 
the start of the infection. In order to investigate whether or not there was a true 
increase in MRSA infections, only the first positive S. aureus isolate from each 
person was considered. 
Upon determination of infection or colonization with staphylococci, we 
analyzed the cases to categorize them into one of two groups: hospital-acquired 
or community-acquired. Further breakdown of the two groups separated them 
into patients who were either infected or colonized. Cases were defined as 
hospital-acquired if the sample that was positive was collected 48 hours after the 
patient's admission date. Conversely, cases were defined as community- 
acquired if the positive culture had been obtained within 48 hours of admission. 
For consistency, these are accepted definitions used by the infection control 
community which take into account the general incubation periods of common 
bacterium. 
The analysis of the medical records was conducted with the guidance of a 
surveillance sheet or check list which included the demographics described in the 
following paragraph. The data collected on these sheets were eventually used to 
compile the working case line listing. Data regarding unit and room location of 
admission, age, gender, past medical history and whether the patient came from 
home or an alternate residence such as an extended care facility was compiled. 
Project I: A chronological report of the recovery of S. aureus isolates as 
reported by the microbiology laboratory over a nine-year period 
from January 01,1997 through December 31,2005. 
A. Background 
For the last decade, because of growing awareness of the impact of 
antibiotic resistant strain of organisms, it is important that health-care facilities 
are aware of the prevalence of infections with these organisms among their 
inpatient population. An in-depth review of these positive cases, commor~ly 
referred to as "surveillance," is routinely conducted by the lnfection Control 
Department. Because of the necessity of timeliness and efficiency, and the 
meaningfulness of such data, surveillance has undergone a change over the past 
decade from hospital-wide to targeted (Hoffman 2000). Targeted surveillance is 
restricted to specific concerns (types of infections or organisms causing those 
infections) or risk determined priorities as identified by the lnfection Control Plan 
specific to each institution. At Hospital A, one aspect of the targeted surveillance 
program is of epidemiologically significant organisms such as MRSA. The 
characteristics and epidemiology of all MRSA infections are reviewed and the 
infections are defined as hospital-acquired or community-acquired. The results 
of this surveillance are reported to the lnfection Control Comrr~ittee on a monthly 
basis to identify any occurring trends in terms of person, place and time and 
determine required action for the prevention and control of these infections. 
The following is a chronological report of the recovery of S. aureus 
isolates as reported by the microbiology laboratory over a nine-year period from 
January 01, 1 997 through December 31,2005. Also included is a specific focus 
on the time period January 2001 through December 2001, which has resulted in 
the identification of significant shifts in the epidemiologic trends of these 
organisms in the inpatient population at Hospital A. 
During the time period of 1997 through 2000, we identified increasing 
numbers of this clinically important, antibiotic-resistant organism. Additionally, 
during the time period of January 2001 through Decerrlber 2001, it appeared that 
the number of isolates identified as positive for MRSA increased significantly. 
We were interested to see if there was a proportional increase of MRSA isolates 
to MSSA isolates and if there was a point in time that indicated a spike in the 
total number of MRSA isolates. Further, we were interested to see if there was a 
trend that showed an increase in MRSA isolates in relation to colonization or 
infection and the identification of factors predisposing these patients to 
acquisition of this organism. 
B. Specific Methods 
In addition to the methods described in the overview are the following 
methods of research specific to the investigations reviewed in this section. In 
order to account for the proportion of MSSA isolates to MRSA isolates identified 
by the Hospital A Microbiology Laboratory from 1997 through 2005, we 
conducted a review of the isolates positive for S. aureus retrieved from the 
Microbiology Laboratory computer system. 
Additionally, a review of the monthly Infection Corltrol Committee minutes 
and a line listing of patients with isolates positive for MSSA and MRSA have 
been reviewed in order to define clinical impact and to determine the prevalence 
of infection and risk factors predisposing patients to acquiring infections positive 
for MRSA over a one-year time period. 
C. Results 
Review of the data showed that most patients who had samples sent to 
the laboratory which tested positive for S. aureus had more than one culture sent 
during their hospital admission. Therefore the total number of isolates positive 
for S. aureus was approximately two times greater than the number of patients 
who had cultures positive for S. aureus. However, when using the criterion of 
counting or~ly ,the first culture identified as positive, we demonstrated support of 
our hypothesis of an increase in the number of isolates positive for S. aureus. 
The total number of S. aureus isolates identified by the laboratory per study 
criteria for inclusion is illustrated in Figure 1. 
Figure 1 
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YEAR 
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Additionally, when the number of isolates positive for S. aureus was 
compared to the annual inpatient census, we found that the number of isolates 
positive for S. aureus, one per patient, had continued to increase overall during 
this time period. 
In order to identify any change in the proportion of MSSA to MRSA 
isolates the total number of S. aureus isolates was reviewed. The nun-~ber of 
isolates positive for methicillin-sensitive S. aureus is depicted in Figure 2; and, 
the total number of isolates positive for S. aureus paralleled this pattern (Fig. I). 
Figure 2 
Total Number of Methicillin Sensitive Staphylococcus aureus 
Isolates One Isolate per Patient Identified per Year from 
January 1,1997 through December 31,2005 
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The analysis of the number of isolates positive for MRSA over the nine 
year period depicted in Figure 3 shows a trend of overall increasing numbers of 
isolates. 
Figure 3 
Total Number of Methicillin Resistant Staph. aureus IsolatesOne Isolate 
per Patient Identified per Year 
from 
January 01, 1997 through December 31,2005 
YEAR 
Next, a chi square test for independence was conducted to determine 
whether the increasing trend of isolates positive for MRSA was statistically 
significant. The increase in the number of patients with cultures positive for 
MRSA in 1997 versus 2005 was found to be statistically significant with a P value 
The numbers of isolates positive for MSSA in comparison to MRSA in 
relation to the total number of isolates positive for S. aureus are depicted in 
Figure 4. The figure illustrates the gradual increase in proportion of MRSA to 
MSSA. As of 2005, MRSA comprised the majority of the identified strain for all S. 
aureus isolates. 
Figure 4 
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The data illustrated in Figure 5 more specifically demonstrates the 
relationship of isolates identified as MRSA in comparison to the overall nurr~bers 
of isolates identified as positive for S. aureus. The data shows that in the year 
2001, of all isolates positive for S. aureus, 70% were identified as MRSA 
compared to 30% MSSA. Additionally, over the entire time period studied, 
approximately 50% of all isolates identified as S. aureus were methicillin 
resistant. 
Figure 5 
Percent of Staphylococcus aureus Isolates 
that were Resistant to Methicillin 
1997- 2005 
Year 
-The proportion of MRSA to MSSA in relation to overall number of isolates 
positive for S. aureus has increased in recent years. While there had been some 
increase in the total number of isolates positive for S. aureus, the most startling 
result was that the number of isolates positive for MRSA was increasing until 
2 3 
2001. From 2002 through 2005 the percentage of MRSA remained consistent. 
MRSA was replacing MSSA as the largest portion of S. aureus isolates identified. 
This is shown in Figure 6 as the rate of positive isolates of S. aureus, MSSA and 
MRSA, per 1000 patient admissions. 
The Percentage of Isolates Positive for MSSAcompared to MRSA per 1000 
Patient Admissions from January 1997 through December 2005 
Figure 7 illustrates the trend of these organisms over time. It depicts 'the 
number of isolates per 100 discharges in relation to the total number of isolates 
positive for S. aureus, one per patient from January 1997 through December 
2005. 
Figure 7 
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We determined that the apparent increased trend in isolates positive for MRSA, 
one per patient, was statistically significant using the chi square test. We noted 
that the increase in isolates identified as positive for MRSA from 1997 versus 
2001 was approximately three times as great and was statistically significant with 
a P value < 0.001. 
Furthermore, an increase in the proportion of isolates positive for MRSA in 1997 
versus 2005 showed that patients were noted to be four limes as likely to be 
positive for MRSA in 2005 when compared to 1997. The data reflecting ,this 
analysis is shown in Table 2. 
Table 2. The Percentage of Patients identified with Isolates Positive for 
MRSA for the Time Periods of 199712001 and 199712005 
A further analysis of the data was completed to identify cases of clinical 
interest consistent with our definition of infection and identified as positive for 
methicillin-resistant S. aureus. The data demonstrated an increasing prevalence 
of infections positive for MRSA were being identified in our hospital, as seen in 
Figure 8. 
Figure 8 
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Inpatients from January 1,1998 through December 31,2005 
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A chart review to determine characteristics of the clinical status of patients 
positive for MRSA infection was conducted in an effort to identify potential 
elements predisposing patients to developing these infections. Analyzing the 
data obtained from the clinically significant cases, we found that the mean age of 
the patients with infections positive for S. aureus was 61, with a slightly higher 
number of males than females. The majority of these patients had been residing 
at home, with the second highest patient population admitted from an extended 
care facility. Also included were patients who had been born in the hospital and 
directly admitted to the Neonatal lntensive Care Units. 
Of these patients with infections, the majority were noted to have been 
admitted to the Adult lntensive Care, Medicine and Surgery units. Most cases of 
these infections were related to blood and pneumonia. Urinary tract infections, 
wounds and abscesses were identified more frequently on the medical and 
surgical units. A particular concentration or prevalence of infections involving 
abscesses was noted on the Department of Corrections unit. Also noted was a 
higher incidence of infections which were identified in the neonatal population 
over a one year period and primarily manifested as eye, trachial and blood 
infections. 
Of significant interest to an infection control program is the nurr~ber of 
infections positive for MRSA designated as community-acquired in comparison to 
hospital-acquired. The implication of cases identified as hospital-acquired is of 
potential transmission of the organism to the patient in relation to appropriate 
infection control practice adhered to by the health-care providers. The number of 
hospital-acquired infections positive for MRSA increased consistently through 
this time period, as illustrated in Figure 9. 
Figure 9 
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Specifically, we identified that during January 1, 1999 through December 
31, 1999 and January 1,2001 through December 31,2001, there was a large 
increase in the number of infections that were positive for MRSA. The increase 
in the number of infections during the year 2001 was 50% greater than the 
previous year. We were interested in identifying any changes in epidemiology 
which may have been responsible for the persistent increase in infections 
positive for MRSA from this time period forth. 
A remarkable discovery from this investigation was the consistent increase 
in the number of infections positive for MRSA which were determined to be 
community-acquired, as illustrated in Figure 10. 
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During the time period of January I, 1998 through December 31, 1998, all 
infections identified in the inpatient population as positive for MRSA were 
considered hospital-acquired. However, over the next seven years a remarkable 
trend in the epidemiology of this pathogen was identified in our hospital, as noted 
in Table 3 below. 
Table 3. The percentage of hospital-acquired MRSA infections compared 
to the number of community-acquired infections identified at 
The relationship between infections positive for hospital-acquired MRSA 
as compared to community-acquired infections is illustrated in Figure 11. It is 
clearly depicted that in 2001 the number of infections positive for MRSA identified 
as community-acquired surpassed the number identified as hospital-acquired. 
Figure 11 
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Further analysis of what appeared to be a pivotal year was conducted with 
a retrospective study of the time period of January 2001 through December 
30 
2001. We found that during this time period ,the microbiology laboratory identified 
601 isolates of S. aureus from 291 patients (approximately 2.06 isolates per 
patient). Of the 291 isolates positive for S. aureus, 24.1 patients were infected 
and 50 were determined to be colonized. Therefore, 241 patients fulfilled the 
criteria for inclusion in the study. Table 4 illustrates the specific pathogen (MSSA 
or MRSA) and whether or not they were hospital-acquired or community-acquired 
cases for these 241 patients. 
Table 4. 
MRSA 94 (40%) 39 (42%) 1 55 (58%) I 
MSSA 147 (60°/o) 
This corr~parison between MSSA and MRSA and hospital-acquired versus 
community-acquired is depicted in Figure 12. 
62 (42%) 85 (58%) 
Figure 12 
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To further analyze the characteristics of these four groups designated as 
MSSA or MRSA and hospital-acquired or community-acquired, a summary of the 
analysis of the data are documented in the following two tables. Table 5 reflects 
the demographics of the patients with infections positive for MSSA which were 
identified as hospital-acquired or community-acquired as compared to the 
characteristics of patients identified with infections positive for hospital-acquired 
and community-acquired MRSA infection noted in Table 6. 
Table 5. Characteristics of 147 patients identified as positive for an 
infection positive for MSSA; hospital- acquired and community- 
*We attributed the relatively young age of patients in the extended care facility group as being a 
reflection of the inclusion of the Department of Corrections patients and patients admitted from 
sub-acute rehabilitation facilities. 
Age, mean 
**Neonates born in this hospital were considered to have an admission source categorized as 
hospital and were automatically considered hospital-acquired cases. 
***Date of admission counted as day one. 
36 
(58%) 
Table 6. Characteristics of 94 patients identified as positive for an 
infection positive for MRSA; hospital-acquired and community- 
Admission Source 
acauired 
(42%) 
ECF 
Home 
Hospital 
Mean Number of 
Days from 
Admission until 
First Positive 
Isolate 
1 Gender I Male 25 ( Female 14 ( Male Female 27 (66%) ) 
(62%) 1 
53 55 
17 
37 
**8 
***20.32 
*34 
15 
0 
Unknown 
Aae. mean 
Admission Source 
of Days from 
Admission until 
First Positive 
Isolate 
(47%) 1 (34%) 
69 
28(53%) I 
67 
22 
33 
ECF 
Home 
0 
Unknown 
Hospital 
, Mean Number 
13 
25 
1 
10 
Of the patients with community-acquired MRSA who were admitted from 
home, slightly more were females than males (19 females and 14 males). A 
similar proportion of females to males (8 females and 14 males) were found in 
cases admitted from Extended Care Facilities; which includes the cases admitted 
from prison. Because the numbers of patients in these sub-categories are small 
we found no significant relationship between gender and infection with MRSA. 
An important consideration is to identify inpatient populations who may 
have characteristics that predispose them to a higher risk of acquiring an 
infection with MSSA or MRSA. We analyzed the number of positive infections 
related to physical sites of infection and which hospital units had the highest 
rates of infections with these body sites. The percentages of infections and 
locations of occurrence are described in the following paragraphs. 
In order to identify specific patient populations at greatest risk for 
acquisition of these pathogens, we determined the patient care areas with the 
highest rates of infection with these organisms, as illustrated in Table 7. 
Table 7. Identification of Infections positive for hospital-acquired and 
0 
1 PSYCH 1 I 1 I I I I I 
iOB/GYNepL 6 
0 
ICU 
CSDU 
As illustrated in Table 8, the greatest percentages of hospital-acquired 
infections positive for MSSA were found in the Adult ICU, Surgery 7 and 
Medicine 4, in descending order of magnitude. The greatest percentage of 
hospital-acquired infections positive for MRSA was identified in the Adult ICU, 
followed by Surgery 7 and Medicine 4 with equal percentages. 
15 1 10 1 13 1 13 1 51(21%) 
ONC 6 
0 
0 
1 
SURG 7 
Totals 
PSYCH 3 0 4(1.7%) 
0 
0 
1 
MED 4 
1 NIEDISURG 5 
13 
62 
6 (2.5%) 
1 (0.4%) 1 
3 
12 
6 
19 
3 
33 
10 
9 
8(3.3%) 
85 , 39 
9 
0 
12 53(22%) 
55 
23 
3 
24 1 
77(32%) 
19 (7.9%) 
Table 8. Identification of Infections positive for hospital-acquired MSSA 
and MRSA with percent of total MSSA~MRSA infection by hospital location 
Hospital Unit 
NlCU 
OBIGYN 
ICU 
CSDU 
PSYCH 3 
MED 4 
MEDISURG 5 
We determined that the most frequent sites of infection identified as 
positive for MSSA or MRSA and either community-acquired or hospital-acquired 
were blood, sputum, and wounds, as illustrated in Table 9. 
Mwbm 
~~n 
9 (15%) 
0 (0%) 
SURG 7 
Totals 
Table 9. Hospital-acquired and Community-acquired cases of MSSA and 
HA MR$&'", 
I n ~ U ~  Totals 
1 (3%) 10 
0 (0%) 0 
PSYCH 1 , I (1.6%) 
15 (24%) 
1(1.6%) 
2 (3.2%) 
12 (19%) 
6 (9.7%) 
MRSA according to physical site of culture acquisition. 
sites of 
Infection H U U S A  CA-MSSA , HA- , CAYRSA 
13 (21%) 
62 
1 Blood I 11 / 20 1 5 1 10 1 
0 (0%) 
2 (5.1%) 
9 (23%) 
0 (0%) 
I Urine I 2 I 9 I I I 4 I 
4 
2 1 
6 
9 (23%) 
39 
i Catheter I 5 1 0 1 2 1 0 I 
1 
22 
101 
1 Wound 1 22 i 25 1 8 1 24 1 
, 
I Trachial As~irate 1 4 / 0 1 1 1 0 1 
1 Bronchial Lavaae 1 0 1 2 I 1 1 0 1 
1 Fluid 1 2 1 3 1 0 / 1 1 
( *Other 3 1 5 ( 0 / I 1 
*Other body sites include samples taken from: stool, cervix, peri-anal, eye and nasopharyngeal 
Table 10 illustrates the specific sites of infection, the pathogen and the unit with 
the highest rate of those infections. 
Table 10. Three most prevalent sites of infection percentage HA-MSSA as 
Adult ICU 1 'Sputum 1 8 (62%) 1 10 (53%)-1 
I I 
Med 4 /Adult ICU 1 I Blood 1 5 (46%) /3(27%) 1 2 (40%each unit) 1 
I I I 
'We observed that patients admitted to the Intensive Care unit were much more likely to develop 
respiratory infections with MRSAIMSSA than any other unit in the hospital. Additionally, of the 
patients who developed a Staph aureus respiratory infection while in the ICU, there was a 56% 
chance that a patient would develop an infection positive for MRSA as opposed to a 44% chance 
of developing an MSSA respiratory infection. 
Surgery 7 1 **Wound 1 9 (41%) 
"The majority of wound infections identified as positive for MRSA were community-acquired. 
Wound infections positive for MRSA which were identified as hospital-acquired accounted for 
approximately '/4 of all wound infections positive for MRSA. Wound infections identified as 
positive for MSSA were similar in proportion. Additionally, of the 16 patients on Surgery 7 who 
developed hospital-acquired wound infections with S. aureus, there was a 56% chance it would 
be MSSA as opposed to MRSA. 
7 (88%) I 
Of the 241 patients identified with having an infection positive for S. 
aureus, 79 (33%) involved wound infections. Twenty-two (28%) of ,the total 79 
wound infections positive for Staph were found on the Surgery 7 unit. 
When we looked only at those patients who had hospital-acquired 
infections, 30 (30%) involved wound infections. Over half (16) were identified on 
the Surgery 7 unit. Of these 16 wound infections, 9 (56%) were identified as 
hospital-acquired MSSA and 7 (44%) were hospital-acquired MRSA. 
A total of 46 blood stream infections were identified from the inpatient 
population as positive for either MSSA or MRSA. Of the total 39 hospital- 
acquired MRSA infections, 5 (1 3%) were isolated from blood in comparison to 
the 10 (1 8%) community-acquired MIRSA infections. Additionally, of the 62 
hospital-acquired MSSA infections, 11 (18%) were isolated from blood and 20 
(24%) were attributed to community-acquired cases of bacteremia. It appears 
that a patient is 50% more likely to be admitted with a blood stream infection 
positive for either of these pathogens compared to developing a hospital- 
acquired bacteremia. 
During the time period of January 1, 2001 through December 31,2001, 
Hospital A experienced a significant shift in the epidemiology of isolates identified 
as MRSA compared to isolates positive for MSSA. While the number of isolates 
positive for S. aureus may have increased slightly, it became apparent that 
MRSA was increasing in prevalence and in proportion to MSSA. Even more 
remarkable was the discovery that there was a significant increase in the number 
of community-acquired MRSA infections identified in the inpatient population. 
Of the patient population studied during this time period, it appeared that 
those patients admitted to the Adult ICU, Medicine 4 and Surgery 7 were much 
niore likely to develop infections identified as positive for S, aureus and that 
these infections were more likely to involve sputum, wounds or blood. 
Hospital census data from 2001 shows an average length of stay for all 
inpatients was 6.85 days per admission. Of the patients with corr~munity and 
hospital-acquired MRSA, the average length of stay was 17.5 days per 
admission with a median of 11 days per admission. 
D. Discussion 
During the investigation of routine surveillance of epidemiologically 
significant organisms, the identification of a significant increase in isolates 
positive for S. aureus in 2001 prorr~pted an in-depth study of all isolates of S. 
aureus over a nine-year period. We were interested to better understand the 
changing epidemiology of S. aureus identified as infections in our inpatient 
population. The report of isolates identified as positive for MSSA and MRSA by 
the lab indicated that in the year 2001 there was a significant increase in the 
number of isolates positive for MRSA in the inpatient population. Nosocomial 
transmission of this pathogen resulting in increased nurr~ber of infections was a 
concern of the infection control program. The largest increase in isolates positive 
for MRSA appeared to occur first in 2001. The null hypothesis was that the 
expected incidence of MRSA in the inpatient population would be equal to the 
1997 rate. A chi square statistical test for independence was used. The 
increasing number of isolates positive for MRSA comparing 1997 versus 2001 
was shown to be statistically sigr~ificant, indicating that this increase in incidence 
had an impact on patients and hospital-systems in the early part of the decade. 
Using the chi square statistical test to compare the incidence of MRSA positive 
isolates in 1997 and 2005 resulted in a value indicating strong support for 
rejecting the null hypothesis. The significant increase in incidence of MRSA in 
1997 versus 2005 based on statistical analysis was unlikely to occur by chance 
alone. 
Hospital-acquired infections are a serious problem affecting large numbers 
of patients in all venues of healthcare and institutions despite consistent, routine 
efforts to inhibit transmission of pathogens. Infection control policies and 
procedures such as the use of Standard Precautions for all patients to protect the 
health-care provider and patient from exposure to potentially infected blood and 
body fluids require the use of gloves and other additional protective barriers. 
Another important component of Standard Precautions is hand hygiene, which 
has been identified by the CDC as the primary mode to prevent the transrr~ission 
of infection. Hand hygiene with alcohol-based waterless hand sanitizer or 
antimicrobial soap and water must be performed by health-care providers in a 
thorough and consistent manner. 
In addition to Standard Precautions, Contact Precautions are implemented 
for patients who have an infection positive for epidemiologically significant 
organisms such as MRSA. Contact precautions require the heath-care provider 
to use protective gear such as gloves, gowns, and masks and goggles to protect 
mucous membranes and eyes from droplets. Infective droplets could be 
generated if procedures are conducted creating aerosols such as suctioning a 
patient. 
Hospital-acquired infections are adverse patient events that affect 
approximately two million persons annually according to Cosgrove, et al., (2005). 
Nosocomial infections, also referred to as hospital-acquired infections, are 
potentially caused by many factors such as break in infection control practice, 
significant exposure to environmental contamination, lack of appropriate use of 
personal protective equipment such as gowns and gloves and exposure of the 
patient to multiple, highly invasive procedures and devices. Some examples of 
infections that are device related are ventilator-associated pneumor~ias, central 
venous catheter related blood s,tream infections and postoperative surgical 
wound site infections. These infections occur throughout hospital populations 
and, consistent with the results of our investigation, are more prevalent in areas 
such as intensive care units that are characterized by frequent use of invasive 
devices. This equipment is commonly used in patient care for ventilator support, 
hemodynamic monitoring and infusions. 
Another possible rationale for the higher numbers of infections positive for 
MRSA in .these areas was discussed by Cohen, et al., (2006). The frequent and 
expansive use of antibiotics with critically ill patients causes antibiotic pressure, 
which would increase the incidence of resistant organisms. Because of the 
prevalence of these organisms, transmission of multi-drug resistant pathogens 
would occur from patient to patient via the contaminated hands of direct patient 
care providers on a more frequent basis. 
In an article published in the American Journal of Infection Control in 1996 
describing the data reported from the National Nosocomial Infections 
Surveillance (NNIS) System between 1990 and 1996 (NNIS, 1996), it was 
determined that S. aureus was the most common cause of hospital-acquired 
infections. S. aureus was also identified to be the leading cause of nosocomial 
pneumonia and surgical site infections and the second leading cause of 
nosocomial bloodstream infections, findings which are consistent with the data 
,from our investigation of 2001. 
Investigators have identified S. aureus as a leading cause of blood-stream 
infections among the hemodialysis patient population, with increasing prevalence 
of antimicrobial resistance and severity of illness. Reed, et at., (2006) discussed 
the outcomes among hemodialysis-dependent patients with MRSA compared to 
MSSA bacteremia. As one would expect, the patients with bacteremia positive 
for MRSA had higher mortality, length of hospital stay and cost of care. 
In addition to the increased prevalence of infections positive for S, aureus, 
our study discussed the increased proportion of MRSA to MSSA isolates per total 
nurr~ber of isolates positive for S. aureus. This discovery is supported by the 
conclusions from a cohort study in the United Kingdom by Wyllie, et al., (2006). 
These authors discussed the emergence of a significant increase in the number 
of patients identified with bacteremia which was positive for MRSA while the 
nurr~ber of those positive for MSSA stayed the same. 
It is well documented in the literature that infections with multi-drug 
resistant organisms contribute significar~tly to increased length of stay which 
increases cost. Pittet, et al., (1 994) reviewed the impact of hospital-acquired S. 
aureus infections in New York City hospitals, showing the affect on lerlgth of stay 
for critically ill patients. These infections were found to increase length of stay in 
the intensive care unit by 8 days and their total hospital stay by 14 days. 
Brachman, et al., (1980) found that postoperative wound infections increased the 
patient's length of stay an average of 7.4 days. We found the average length of 
stay for inpatients during 2001 to be 6.84 days per admission as compared to 
17.5 for those patients who were identified with infections positive for MRSA, an 
average of 11 additional days. The increased length of stay burdens patients 
with hardship and risk such as additional antibiotic treatment; subsequent returns 
to the operating room for debridement of wounds, incision and drainage 
procedures and transfers to the Intensive Care Unit for monitoring and 
stabilization of the their physical status. 
Increasing hospital and community-acquired infections positive for MSSA 
and MRSA have been documented to have a substantial negative impact on the 
patient population and health-care facilities, a finding supported by the data 
generated from our investigation at Hospital A. The magnitude of effect depends 
upon several factors, such as specific pathogen, resistance to individual 
antimicrobials, and even the pathogen's mechanism of resistance. 
A concern of any lnfection Control Program is the risk of transrr~ission of 
these pathogens to patients. In order to protect the patients and health-care 
providers from acquiring these organisms, specific infection control practices are 
put into place. These interventions are nationally accepted standards issued by 
the CDC for isolation precautions developed by the Healthcare lnfection Control 
Practices Advisory Committee (Siegel, et al., 2007a) and for the control of multi- 
drug resistant organisms (Siegel, et al., 2007b). 
Hospital A requires contact and in some cases droplet isolation 
precautions once a patient is identified as positive for an infection with MRSA 
and other multi-drug resistant organisms (MDRO). This practice increases the 
amount of time required for staff to prepare themselves to enter these patients' 
rooms prior to providing direct care. Facilitation of this intervention is also 
dependent on the involvement of other employees. Materials Management staff 
provide and replenish supplies necessary to maintain isolation and housekeeping 
staff dispose of the additional trash and adhere to policies specific to clearling of 
these rooms. Hospitals incur considerable expense providing these services and 
the personal protective equipment to maintain precautions. 
Ideally, once identified as having an infection positive for MRSA, the 
patient is placed in a private room, posing a significant issue for our institution 
because of the limited number of private rooms. If all these rooms are occupied, 
patients with infections positive for the same organism may be "cohorted" or 
placed in the same room. The least favorable scenario is that there are no other 
patients positive for MRSA and the unit has restricted bed availability, resulting in 
placement of the patient in a room with another patient who is the least 
susceptible to infection. Evaluation and decision making for the placement of 
these infected patients is instituted on a case-by-case basis and is time 
consuming. These discussions involve the infection control practitioner and 
generally the nurse caring for the patient, assistant nurse manager, nurse 
manager and nursing supervisor. If a room must be changed during a patient's 
hospital stay, he or she may find it confusing and disruptive. Communication with 
patients and families is essential for a successful hospital stay. A significant 
amount of additional time and emotional energy is expended in comforting and 
educating patients and families about the requirement for isolation precautions. 
It has been our experience that they are fearful of the concept of having acquired 
an infection with a resistant organism and of changes in routine care such as the 
need to use personal protective equipment. In an attempt to address this issue, 
the Infection Control Department has developed Patient and Visitor Information 
Sheets on MRSA and other epidemiologically significant organisms (see 
Appendix A). 
In addition to the need to prevent the spread of infection, another 
significant impact the increased prevalence of MRSA infections have had on our 
hospital relates to the initiation of empiric antibiotic treatment. The usual 
treatment initiated prior to obtaining the sensitivities of a specimen result 
identified as positive for S. aureus historically was a P- lactam antibiotic or semi- 
syn,thetic P- lactam antibiotic. Over the course of the past eight years, as the 
epidemiologic trend has shifted, hospital staff have been educated about 
increased identification of isolates positive for MRSA. As a result, physicians at 
our hospital are more inclined to order the administration of vancomycin for 
treatment of these infections in high-risk populations. Antibiotics that are 
effective in the treatment of these pathogens may be initiated but may be 
changed if the organism is identified as mettricillin sensitive. According to other 
recent studies, this has become the recommended practice for populations 
identified as high-risk for infections positive for MRSA in geographical areas with 
high rates of endemic MRSA. A potential unintended and dangerous 
consequence of this change in treatment is that this methicillin-resistant S. 
aureus will also develop a resistance to vancomycin with overuse, limiting 
effective choices of antibiotics even further. 
Another method to control the spread of MRSA is eradication of 
colonization status of patients. Many studies related to the identification, control 
and eradication of MRSA colonization have been published. In one such study of 
Rhode Island hospitals conducted by Arnold, et al., (2002), a change in the 
pattern of susceptibility of MRSA to vancomycin was reported by one of the 
hospitals. This charlge supports the concern about the increasing limitation of 
antibiotics available to provide effective treatment of these resistant infections. A 
common recommendation for prescribers is to adhere to judicious use of 
antibiotics in both hospital and community settings. Its purpose is to reduce the 
evolution of multi-drug resistant organisms by avoiding the excessive and 
unnecessary use of antibiotics resulting in what is referred to as "antibiotic 
pressure." An important initiative by many facilities is the development of an 
anti biotic stewardship program. As discussed by Lesprit and Brun-Buisson 
(2008), these programs are developed with the intention of monitoring cost and 
effectiveness of antibiotics and putting practices into place to eliminate antibiotic 
overuse, thereby preventing antimicrobial resistance. These programs require 
dedicated and committed staff and demand additional funding from facilities for 
support. 
In addition to health-care activity within an institution for the prevention 
and control of these infections, a major concern of public health is the education 
of the general public regarding these important health issues. Patients can be 
discharged from their hospital admission to the community and may continue to 
be positive for MRSA colonization. These patients hopefully return to their 
activities of daily living including school and work. The media has paid a 
tremendous amount of attention to MRSA, presenting it to the general public as a 
new and unknown entity to be feared. Additionally, hospitals are shown to be 
'Filthy as described in newspaper articles and on television potentially inflaming 
the fear. The lay public has been led to believe that MRSA represents a 
"Superbug" epidemic rather than being an epidemiologically significant but 
treatable pathogen that has been around for half of a century. Special interest 
gro1,lps are demanding that specific actions be taken by hospitals to control the 
"spread "of these infections, without medically-based evidence of ,their efficacy 
i.e., global MRSA screening for all patients upon admission to the hospital. The 
general population lacks the ability to recognize the "unintentional" 
consequences which may occur. Universal "screening" of patients admitted to 
health-care facilities which have been proposed by some states and special 
interest groups could potentially cause a severe financial strain on the health 
system. Additionally, as discussed by Diekema, et al., (2001), active screening 
has yet to be proven effective. Little guidance is available to hospitals as how to 
handle appropriately the patients and health-care workers who are identified as 
positive for MRSA colonization. The current recommendation is to avoid 
decolonization of asymptomatic carriers for several reasons, such as inefficient 
sustained "decolonization" of some individuals in addition to potential 
development of resistance to treatment, which is typically mupirocin. 
Additionally, a study by Harbarth, et al., (2008) discusses some of the obstacles 
of universal screening including cost of equipment, a greater than 20-hour 
turnaround time for results and number of private rooms available for isolation 
per facility. 
The discordant relationship between a patient's beliefs and accurate 
knowledge can be large. A descriptive pilot study of 11 0 patients by Madeo, et 
al., (2008) was conducted in the United Kingdom on the perceptions and beliefs 
of inpatient populations regarding infections. They found that the majority of 
patients believed they had adequate knowledge of hospital-acquired infections. 
Upon admission to the hospital they were able to iden,tify by name pathogens 
common to hospital-acquired infections such as MRSA. However, the patients 
expressed uncertainty about the modes of transmission. The majority of patients 
cited the news media as the major source for their education on hospital- 
acquired infections, but about 50% felt that the information delivered by the 
media was not always accurate. This study supports the need to provide 
appropriate education to hospitalized patients as well as the general population. 
It is important for the public to become appropriately educated and 
knowledgeable about steps hospitals are currently taking to prevent the 
transmission of MRSA, and the steps they, themselves, can take to prevent 
exposure to this organism. The burden of this education should fall squarely on 
public health agents and health-care providers to ensure that a clear, concise 
and medically accurate message is delivered. 
As this investigation has demonstrated, MRSA is now found largely 
in the community setting and is no longer only considered a hospital-acquired 
pathogen. In addition to routine infection control precautions, we at Hospital A 
have routinely educated hospital personnel on the specific policies and 
procedures, consulted and collaborated with hospital staff to place patients in 
proper room assignments, educated patients and families, conducted targeted 
surveillance and managed potential outbreaks. Connecticut hospitals including 
Hospital A have taken further initiatives to address the issue of this significant 
pathogen. The Connecticut Hospital's Association (CHA) has organized an effort 
to create a "Pledge," which is a position statement to the general public and to 
the state legislature on an individual facility's plans to reduce infections positive 
for MDRO's. The pledge includes statements about continuing to enforce and 
monitor good infection control practices, assist in educating the public and others 
and screen for MRSA specific patient populations assessed as high risk by the 
Infection Control Department. Acute-care facilities have been developing a 
culture of patient safety which includes the prevention of hospital-acquired 
infections and have implemented numerous programs to aid in these initiatives. 
There is significant evidence that has been published suggesting positive patient 
outcomes with the development of patient empowerment and educational 
programs. One example of a successful patient empowerment initiative has 
been developed at Hospital A. The initiative evolved from the Hand Hygiene 
Committee, which has developed a program for monitoring, analyzing and 
improving hand hygiene compliance. A program entitled "JUST ASK" was 
initiated as an empowerment strategy to encourage patients and families to ask 
their health-care providers if they have washed their hands before caring for 
them. Signs explaining 'the program are placed on the patient's doors and 
colorful badges illustrating the "JUST ASK motto are given to the health-care 
provides to attach to their identification badges after they are educated on the 
meaning of the slogan We found that employees want a badge to "belong" to the 
group. McGuckin, et al., (2001) found a 50% increase in hand washing 
compliance when patients were empowered to ask their health-care providers if 
they had washed their hands. Interestingly, a little over half of the patients 
enrolled in the study felt comfortable asking their heal,th-care providers this 
question. Of those who were comfortable asking, nearly 80% received favorable 
"yes" responses. All the patients who participated in the study were comfortable 
asking their nurses if they had washed their hands, while only a small portion, a 
little over a third of the participants, asked their physicians. At Hospital A we have 
seen an increase in hand hygiene compliance from 35% before implementation 
of the "JUST ASK" campaign and other interventions to 77-80% compliance. 
A second action taken to prevent hospital-acquired infections at Hospital A 
was the establishment of a Central Venous Catheter-Related Blood Stream 
Infection subcommittee in December of 2005. Although the incidence of 
catheter-related blood stream infections positive for MRSA identified in the Adult 
Intensive Care Unit was less than that for other pathogens during our study 
period, the health consequences for a patient who acquires an illness caused by 
a multi-drug resistant organism can be serious. Salgado, et al., (2003) looked at 
several studies to see if there was a difference in severity of illness caused by 
MRSA as compared to MSSA in the hospital setting. These studies found 
increased length of hospital stay (1 to 38 days), indicating increased severity of 
illness due to the acquisition of infection with this pathogen. The Hospital A 
subcommittee developed a program which adhered to CDC guidelines for the 
monitoring and assessment of central line infections. We found that our baseline 
rate for central venous catheter (CVC) related blood stream infections (BSI) in 
the adult ICU was 7.05 per 1,000 catheter days. After the implementation of a 
central line bundle that includes proven steps to reduce infection, we reduced our 
infection rate to 1.03 infections per 1,000 catheter days. With the cost of central 
line infections estimated at approximately 20,000 to 30,000 additional dollars per 
infection and up to 50,000 additional dollars for infections positive for MDRO's, in 
addition to the hardship one suffers, this becomes a significant infection issue to 
address on behalf of the patient and the health-care system. 
An important component of many of these interventions is the attempt to 
change the "culture" of the institution, encouraging staff of all disciplines to 
become active team members and change agents of the process. One of the 
most important aspects of this process of change is education of employees. 
Coopersmith, et al., (2002) conducted a study at the Washington University 
School of Medicine attempting to lower the rate of CVC related BSI in the Adult 
Intensive Care Unit. One of the most significant efforts that effected change was 
education focused on the nursing staff. Through empowerment of nursing staff, 
they reduced the incidence of CVC related BSI by two-thirds over an 18-month 
period, resulting in a cost savings in the range of $185,000 and $2.8 million 
dollars due to the decrease in infections. 
E. Study Limitations 
A potential flaw in this study is that all isolates for inclusion were identified 
on the basis of one per patient per hospital stay. While surveillance was 
conducted with the use of a data collection tool to ensure consistency and 
adherence to inclusion criteria, these isolates may mistakenly reflect inpatients 
who were colonized, not infected, with these organisms. Also worth noting is that 
even when a patient was identified as infected with an isolate positive for MSSA 
or MRSA, it is possible that another pathogen was causing the signs and 
symptoms of infection. In these cases the identification of colonization with 
MSSA or MRSA was a result of the in-depth targeted surveillance. We believe 
that these circumstances would be unusual and not typically counted because of 
the intense review of the medical record and microbiology laboratory results 
identifying the presence or not of other pathogens. 
Limitations of the Laboratory Medicine computer system have also been 
identified. Many patients who are admitted to Hospital A have several co- 
morbidities which result in multiple admissions within short time periods. The 
number of isolates may reflect a duplicate count of individual patients who have 
had multiple admissions. MSSA or MRSA physical status may not have been 
successfully eradicated, therefore resulting in the identification of a patient with 
isolates positive for these pathogens on more than one admission during this 
time period. 
Additionally, because of the lack of data storage space, the lab is required 
to archive microbiology lab results. During the retrospective study of isolates 
from January 01,2001 through December 31,2001, some discrepancy was 
noted between the data that was collected in real time, for the nine year 
microbiology review and the retrospective one year review. Although some 
discrepancies in the number of positive isolates were identified, such as a lower 
number of isolates retrieved from archived data compared to surveillance data 
collected concurrently, overall trends remained consistent. 
Finally, results inputted into the computer database for microbiology 
laboratory results are person dependent and therefore subject to human error. It 
was discovered during these investigations that lab technicians have the ability to 
"free text" andlor input data in variable ways. This latitude in data entry may 
have' had a major impact on the consistency of the data. For instance, if I, as the 
Infection Prevention Specialist, have learned to retrieve results of isolates that 
were positive for MRSA by identifying these isolates using the code "MRSA," but 
a subset of the lab technicians have entered these positive isolates as "oxacillin 
resistant," the system may not render the total number of isolates positive for 
methicillin resistance. It has been noted that currently the laboratory is 
purchasing a new computer data system. 
Surveillance of this pathogen is ongoing for the purposes of the Health 
Center's infection control program and appears to reflect consistent .trends for 
this organism. It would be beneficial overall to conduct an investigation in the 
same niarlner as documented in this paper to determine if there has been 
consistent change or new trends in the epidemiology of MRSA identifying the 
incidence and prevalence or any significant changes in this patient population 
through the current time period. 
It is well documented that the epidemiologic trends that evolved in the 
patient population of this university hospital over time are consistent with what 
has been identified nationally and in the United Kingdom. The responsibility now 
on healthcare and the general public is to strive for the control and prevention of 
these infections and implement medically evidenced-based practice to inhibit the 
increase in incidence, prevalence and progression of the development of these 
resistant pathogens. 
IV Project II: An Epidemiologic Investigation of  a MRSA Outbreak in  a 
Neonatal Intensive Care Unit 
The following is a report of a cluster of MRSA cases that occurred from 
October 2002 through October 2003 in the Neonatal lntensive Care Unit (NICU) 
at Hospital A while I was conducting normal field surveillance. 
A. Background 
The neonatal population at Hospital A has historically been born from high risk 
mothers whose infants are significantly premature and immunocompromised 
because of their underdeveloped immune systems. As a consequence, these 
infants are at great risk for developing serious illnesses after birth, including 
sepsis and severe respiratory distress. Up until a few years ago, the entire 
neonatal patient population consisted of severely compromised patients. More 
recently, Hospital A's OBIGYN Department has expanded its practice to include 
healthy mothers with uncomplicated pregnancies and non-comprorr~ised infants. 
The NICU area is distinctly separated from other patient care units in the 
hospital. It is located on the ground floor and is protected by an alarm system. 
All personnel and visitors must be identkfied prior to entering this unit. Once 
inside the doors, all staff and visitors are confronted by a large scrub sink. All 
who enter the nurseries are required to complete a full three-minute scrub. 
The two high-risk NICU nurseries and the Special Care Nursery 
consecutively follow each other to form the shape of a letter "C". Each unit has a 
framed windowed entrance as you move from one room to the next. 
To enter into the "C", one must enter through an electronically operated 
glass door. The high risk nursery is divided into three rooms determined by the 
level of acuity of the infant's illnesses, from high risk intensive care to moderate 
and low risk called the Special Care Nursery (SCN). There are approximately 
seven enclosed bassinettes in each of the three subdivisions of the high-risk 
nursery, which is dependent upon patient census. Additionally, a well infant, or 
"normal" Newborn Nursery, is located outside the high-risk core. The "well infant" 
Newborn Nursery, while in close proximity to the other three rooms, is completely 
separate. This unit is surrounded by glass with another scrub sink positioned 
outside its entrance, and one must enter through a separate electronically 
operated door. 
The infants in all the nurseries are cared for in individual isolettes and in 
incubators, both of which provide an isolated environment for each infant. One of 
the high-risk nursery units contains two isolation rooms that are enclosed by 
sliding glass doors and completely separated from the other isolettes in the room. 
The Neonatal Unit has approximately 550 admissions per year and the 
average daily census in the high risk NICU nurseries is approximately 25 infants, 
6 or 7 infants in the SCN and 6 in the "normal" newborn nursery. Typically the 
staff-to-infant ratio is as follows; 2 : l  with few 1: l 's  in the NICU, 3 : l  in the SCN 
and usually 4: l  in the Newborn Nursery. The census in the Newborn Nursery 
varies daily because of the general good health and early discharge of these 
infants. 
During 2001 and 2002, there were several programs that were being 
conducted in this hospital to improve infection control performance; the Neonatal 
Department had been an integral part of these activities as described in the 
following paragraphs. These programs included an evaluation of gloves used for 
infection control purpose, hand washing "blitzes," in-service training and posters 
that promoted hand washing, and "give aways" such as free samples of lotion 
and waterless hand sanitizers used as a reward when someone was "caught" 
washing their hands. Numerous presentations and hospital publications on the 
value of hand washing were delivered. Additionally, waterless hand sanitizers 
containing a 62% alcohol base were strategically placed in convenient areas 
throughout all units to increase accessibility of the hand hygiene products. 
Specifically in the NICU, the waterless hand sanitizers were placed on the 
counter of each infant's designated area. Also, during this time, after a trial of 
several new soap products in high-use areas, an antimicrobial soap solution was 
chosen that contained 2% chlorhexidine gluconate. This component delivers four 
to six hours of persistent effectiveness for reducing resident and transient flora 
on hands of those who use the product. The use of this specific antiseptic is 
recommended by the Centers of Disease Control Hand Hygiene Task Force. 
Prior to the year 2002, there were few isolates of MRSA from infants 
hospitalized in the Neonatal Intensive Care Unit. There were no infections with 
MRSA identified in the NlCU in 1998, three infections in 1999, and none 
identified in 2000 and 2001. In 2001, there was a significant rise in the number 
of MRSA infections throughout the hospital population with the exception of the 
NICU. In March of 2002, an infant was born at Hospital A and admitted to the 
NlCU who had MRSA isolated from an infection in his right eye on the 1 3 ~ ~  day of 
his hospitalization, and he received treatment with vancomycin eye drops. We 
were unable to determine whether or not this infant had acquired MRSA from a 
family member who had been colonized with this organism in the community or 
from hospital personnel. Because most of the infants in the NlCU remain for long 
periods of time in the hospital after birth, virtually all cultures positive for MRSA in 
these highly susceptible patients are considered hospital-acquired. 
Subsequent to this case, neonatologists in the NlCU ordered surveillance 
cultures from infants to identify other potentially colonized patients. 
In September 2002, one infant was found to be colonized from a trachial 
aspirate culture and one infant had an eye culture positive for MRSA. In October 
2002, seven infants were identified as colonized with MRSA in cultures taken 
from axillae, nasopharynx, groin, trachea, sputum and broviac catheter wound 
site. lmmunocompromised infants identified as colonized with MRSA in October 
were treated with antibiotics because of their health status. In November 2002, 
one infant was identified with MRSA bacteremia 15 days after being identified as 
having a colonized broviac catheter insertion site; and 3 other infants were 
identified with MRSA colonization as depicted in Figure 13. 
Figure13 
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By December 2002, we had implemented a number of interventions as a 
result of our surveillance, as we continued to identify new cases. The staff of the 
NlCU was provided training on proper precautions, including contact isolation 
and conscientious hand washing practices, in order to reinforce the role of hand 
hygiene in preventing the transmission of MRSA among the infants. 
Despite these interventions, cases continued to be identified over the next 
12 months. In total, 58 infants were identified with either infections or 
colonization with MRSA. Of these, 29 were infected and 29 were colonized. The 
sites of infection or colonization are displayed in Table 11. The timeframe for 
these identified sites of infection or colonization of infants from whom MRSA was 
recovered was between January 1999 and December 2004. The one case 
identified in January 2004 was from an infant previously identified in 2003. This 
case was not counted to be consistent with counting only the first culture positive 
for MRSA. 
Table 11. Site of colonization or infection identified as positive for MRSA 
Wound 
Resp. Tract 
3 (9.7%) 
Of the total 58 infants with cultures positive for MRSA, 42 had been 
admitted into room one of the two high-risk NlCU areas. Of the remaining 16 
infants, nine had been admitted to the SCN and seven into the Newborn Nursery. 
The infants in the high-risk NlCU and SCN are the most vulnerable and 
seriously ill infants with the longest admissions. The time from birth to the 
identification of first culture positive for MRSA ranged from 5 days to 132 days for 
our 58 cases. (Figurel4) 
1 (3.5%) 
6 (21%) 
I 
0 (0%) 
I 
Totals 
I 
18 (62%) 
Urine 2 (6.9%) 
29 29 
Figure 14 
Time Lapse from Birth to First Culture Positive for MRSA 
Range of Days Describing Birth to Day of First Culture Positive for 
MRSA is Identified 
Of the 42 high-risk neonates whose cultures were positive for MRSA, 24 
(41 %) received antibiotic treatment. 
When their physical condition improves, infants from the NlCU often 
"graduate" to the SCN, where they continue to be monitored by nursing staff, but 
are stable enough to be handled and cuddled on a routine basis. For infants in 
the SCN, the time from birth to identification of the first positive MRSA culture 
ranged from was 15 to 96 days, with six infants positive for colonization and one 
for a blood infection, also known as bacteremia. The infants admitted into the 
Newborn Nursery are "well" children. The time from birth to identification of first 
positive MRSA culture for this room ranged from 6 to 22 days. 
It should be emphasized that the percent of infections versus colonization 
was higher for the immunocompromised infants than the healthy ones. 
To validate that this outbreak of MRSA cases was related to a common 
source, seven clinically significant isolates from infants positive for MRSA 
infection and two isolates from patients identified as positive for MRSA infection 
outside the NlCU were sent to the Associated Regional and University 
Pathologists, Inc. (ARUP) in Salt Lake City for Pulse-Field Gel Electrophoresis. 
The seven isolates were from blood samples from infants diagnosed with 
bacteremia; and two epidemiologically-unrelated isolates of MRSA from other 
units were also sent as a "control." All seven isolates from the NlCU were 
indisti~guishable in pattern from one another; the two controls were different from 
each other and different in sequence from the neonatal isolates. 
B. Specific Methods 
Methods utilized in this section included a case-control study comparing 
infants with infections positive for MRSA to infants with the same admission time 
frame who were free of infections positive for MRSA. An anonymous staff 
screening for MRSA was conducted on employees who had contact with cases 
and controls. 
C. Outbreak Investigation 
In August of 2003, we conducted an intense review of each infected or 
colonized infant's chart to generate a line listing. This assisted us in identifying 
common features that linked one infant with the other (Table 12). We identified 
common exposures, contacts with specific personnel and activity records for the 
infected and colonized infants for comparison with a control group consisting of 5 
infants. The control group was comprised of infants who were the same age, 
were in the same NlCU nursery room for the same length of time, and had similar 
illnesses or procedures, but who were not infected or color~ized with MRSA. 
Once the chart review had been completed, members of our Infection Control 
team met to examine possible common links among the infants. 
Table 12. Components of the line list generated from chart review of 16 infants 
identified as having an isolate positive for MRSA and 5 infants in the 
comparison group. 
I Infant's Name 1 
1 Birth Date 1 
Admit Date 
Room Number 
Isolette Number 
Discharge Date 
Gestational Age 
Weight 
Gender 
Medical Record Number 
Duration of Time from Admission to First Positive Culture 
Site of Culture (If positive) 
Treatment Administered for infection or Colonization with 
r MRSA I 
Each infected and colonized infant had niultiple common exposures, 
activities and procedures during this time period. A significant number of 
personnel regularly had direct patient contact with all infants on a day-to-day 
basis. The line list of individual patient contacts by personnel with cases and 
controls were tallied. (Table 13) We identified six caregivers, all physicians and 
nurse practitioners, who had higher numbers of contact with the cases than 
controls, including one nurse practitioner who appeared to have had the most 
encounters. 
Table 13. Tally of the most frequent exposures of 129 persons employed in 
the neonatal unit to 16 cases of infants who were identified as 
having an isolate positive for MRSA as compared to 5 controls 
* Healthcare Provider of Interest identified as Nurse X 
** Preferred healthcare provider to be tested but was not 
*** Nurse Y and Z with sterile (no growth) results 
While it is not common practice to screen health-care workers for MRSA 
colonization routinely, in outbreak situations it may be necessary to identify a 
source of transmission. A surveillance culture survey for MRSA was initiated to 
identify a health-care provider who may have transmitted MRSA to infants 
identified as infected or colonized. 
We conducted an anonymous screening of the selected health-care 
providers by culturing specimens obtained by nasal swab. The line list of 
employees was created in alphabetical order. The number assigned to the 
employee was where their name fell in consecutive order on the list. The lab slips 
were coded by number; names could not be connected to the sample number 
except by a separate coflfidential list that identified the sample number with a 
name. 
We were able to culture four of the six employees within a one-week time 
period. Work schedules delayed screening of two remaining employees until the 
following week. From the six employees who were screened, four samples were 
positive for MSSA (Methicillin-Sensitive Staph. aureus) colonized from the nasal 
swabs and two samples (from nurses Y and 2) had no growth. It was discovered 
that Nurse X was re-cultured five days after initial screening which originally was 
positive for S. aureus. The result of the second culture showed no growth of any 
organism. Table 13 displays an abbreviated example of the table tallying the 
most frequent exposures of 129 persons employed in the neonatal unit to 16 
cases of infants who were identified as having an isolate positive for MRSA as 
compared to 5 controls. (See appendix for a listing of exposures for all 129 staff 
in the NICU.) 
D. Infection Control Activities 
In an effort to prevent transmission of MRSA to other infants, we adhered 
to the following protocol. Once infants with anterior nares swabs or other culture 
sites were identified as positive for MRSA colonization or infection, they were 
placed in a single room in the SCN and cared for consistently by the same 
caregivers. Intense contact isolation was implemented and caregivers were 
screened by nasal swab for MRSA colonization. . 
Parents of the infants were given a letter explaining modifications in daily 
standard operating practices because of the outbreak of MRSA in the NICU. 
Another information sheet was created for neonatal staff on the modified 
standard practice and in-services were conducted. Information and education 
were free flowing among frontline staff, neonatal administration and infection 
control personnel. 
' To prevent further spread of MRSA in this unit, during the same time that 
the medical record investigation and screening was being conducted, we 
conducted a prevalence survey to identify all colonized infants. Anterior nares 
swabs were obtained from all 37 infants in the NICU room 1, SCN and the 
Newborn Nursery. The staff and MRSA positive infants were then cohorted and 
strict adherence to intense contact isolation was required. The infants who had 
results positive for MRSA from the screening procedures were treated with nasal 
mupirocin to decrease the risk of transmission to other infants. Anterior nares 
66 
cultures and cohorting were done on all infants with cultures previously identified 
as MRSA positive every Tuesday each week until there were four weeks without 
any cultures positive for MRSA. 
Once a previously identified MRSA-positive infant was culture negative 
'from the nares, the infant was re-cultured ,the next week from the anterior nares, 
trachea, axilla, any wound sites, and all intravenous sites. The rationale for 
obtaining cultures from multiple sites was to ensure that we were not changing 
practice based on a false negative result obtained from an anterior nares sample 
that had been treated with mupirocin. Culture-negative infants were moved into 
another area of the nursery. 
Infants who had tested positive in the past and remained hospitalized in 
the NlCU and newly colonized infants were continued on topical mupirocin to 
their nares for the duration of their hospitalizations. 
In October 2003, five additional isolates from neonates with clinically 
significant MRSA infections identified in the previous month were sent to ARUP 
for Page Field Gel Electrophoresis. These five isolates were indistinguishable 
from each other and from the sever1 previously tested specimens. This indicated 
that the index case or source continued to transrr~it he MRSA to additional 
infants as late as September 30, 2003. 
In a prevalence survey in late October 2003, 51 cultures were sent from 
39 infants. One of the cultures returned positive from an infant who previously 
had positive cultures and two others from newly identified patients positive for 
MRSA. The three infants were cohorted in the same area of nursery room 1 and 
a physical screen was placed dividing the room to maximize awareness of the 
contact isolation precautions. The infants were treated with a course of 
mupirocin to their nares. 
Over the next three weeks, approximately 170 nasal swabs were cultured 
for MRSA from 1 10 infants. From these 1 10 infants, only one newly colonized 
patient was identified. Beginning in mid November of 2003, three weekly 
screenings of all hospitalized infants found no infants identified as positive for 
MRSA colonization. The neonatal units continued screening for an additional 
week to ensure that the screening cultures were negative for four consecutive 
weeks. Additional random screening continued as indicated by clinical 
circumstances. Because NlCU infants are significantly immunocompromised 
due to their premature physical status, multiple cultures from many body sites, 
including nares, axilla, and insertion sites for tubes and catheters were cultured 
frequently. 
No further cultures positive for MRSA were identified for two months after 
this cluster resolved. The one culture identified in January of 2004 was from an 
infant who had a culture positive for MRSA in 2003. 
E. Discussion 
During the outbreak investigation in Hospital A, enhanced infection control 
practices were implemented and conscientious infection control practice i.e., 
hand hygiene were enforced. Despite these efforts, cases of colonization and 
infection continued to be identified. However, upon completion of the 
anonymous employee screening, cases of colonization and infection ceased to 
occur. 
Several outbreaks of neonates colonized or infected with MRSA from 
different institutions have been described by Anderson, et al., (2002), and Regev- 
Yochay, et al. (2005). Importantly, an outbreak investigation has been described 
by Bertin, et al. (2006). The outbreak occurred in a level Ill NlCU in a tertiary care 
center. The investigation identified a health care worker who served as a 
reservoir for MRSA. The outbreak included nine of 12 infants who were either 
colonized or infected with MRSA, for an attack rate of 75%. Of the nine infants, 
three had MRSA blood stream infections and six were colonized with MRSA. A 
multidisciplinary task force was convened to develop a plan. Subsequently, a 
seven point plan was implemented. -The plan included the following 
interventions: employees were retrained in cleaning and disinfection procedures, 
infected and colonized infants were cohorted, staff who delivered direct patient 
care to the infants were cohorted, infants who tested positive for MRSA received 
treatment with mupirocin, hand hygiene practices were reviewed and enforced, 
surveillance cultures were conducted on infants three times a week, and contact 
precautions were implemented. Also, the hands of health care workers were 
visually inspected to assure they were free of lesions and that no one had 
artificial nails. 
These measures appeared to be successful for a two-month period during 
which no further cases of infection or colonization were identified. Subsequently, 
two additional infants were identified as colorrized and a month later a third infant 
developed a MRSA blood stream infection. At this time a health care worker 
voluntarily came forth disclosing a history of a previous ear infection which left 
the health-care worker with a residual external dermatitis. Polymerase chain 
reactions were performed on specimens from all infected and colonized neonates 
and the implicated health care worker. The isolates were more than 90% similar, 
suggesting that the health care worker may have been the index case 
transmitting this organism to infants via the hands. The health care worker 
received treatment with mupirocin and was screened as negative initially, but 
became recolonized with MRSA. This individual was reassigned to an adult unit 
and retreated with nasal mupirocin and a topical ear solution. Routine 
surveillance cultures were implemented for infants in the NICU. Once the health 
care worker was removed from the unit, identification of infants positive for 
MRSA ceased. 
The investigation and interventions conducted in our NICU had many 
similar components to this facility's seven point plan, with a couple of significant 
differences. The page field gel electrophoresis conducted on samples in our 
investigation included infants positive for MRSA color~izaZion or infection and a 
control group of patient samples from other units. This methodology 
demonstrated that the samples from .the infants were similar to each other and 
that our epidemic strain was unique to the NICU. While the samples in the Bertin 
investigation were 90% similar, the samples identified in our NICU were 
considered indistinguishable from each other. 
In the Bertin investigation, a health care worker voluntarily offered the 
history of ear infection and subsequent dermatitis. This health care worker had 
nasal colonization with MRSA and a PCR which showed 90% similarity with the 
outbreak strain from infected or colonized infants. In our study none of the 
involved health care workers volunteered a history of infection; therefore, we 
needed to initiate a comprehensive epidemiologic investigation to identify the 
individual having the greatest number of contacts with cases. This investigation 
revealed a single nurse practitioner who had contact with 75% of ,the infants 
infected or colonized with MRSA, and only 40% of MRSA negative controls. 
When a nasal screening survey was conducted on our employees, only two 
initially yielded specimens which showed no organisnis present, suggesting that 
these health care workers may have received treatment with mupirocin to 
eliminate colonization of MRSA. However, we had no direct knowledge that such 
treatment had been received. More significant was the suspect index case, who 
initially had a screening culture with results positive for MSSA and a subsequent 
culture which showed no growth. This added support to the concept that she 
may have self treated. During the time period immediately following our 
employee screening investigation, identification of new isolates positive for 
MRSA from infants ceased. Potential flaws in the screening process were 
noted. In a review of the line list of employees after screening had been 
completed, it was noted that an employee was chosen to be screened who had 
less contact with cases positive for MRSA compared to the employee listed 
above his or her name. Reader error was responsible for identification of the 
wrong employee to be screened. Secondly, an employee on the list of most 
frequent contacts was not chosen even though she had the same number of 
contacts with cases as an employee who was screened. These identified flaws 
in the process could have caused us to miss the identification of the source of 
transmission. Another significant finding was that Nurse X was screened twice 
and that the second culture result was negative, suggesting that she was the 
index case who self-treated. However, it may not be accurate to assume that 
she was the index case because all employees with results positive for S. aureus 
were not re-cultured. They also may have self-treated, but because they were 
not tested again, the other three employees were the ones implicated as possibly 
being the index case. 
Another study by Ben-David, Mermel & Parentau (2008) supports active 
screening of health care workers. This study acknowledges the importance of 
active screening of patients and strict infection control precautions. However, 
despite these control measures, they continued to experience an outbreak of 
MRSA infection and colonization in a burn patient population. Active screening 
of the anterior nares and hands of health care workers in the unit identified three 
employees positive for colonization with MRSA strains identical to those of the 
patients infected or colonized. The employees were treated and MRSA was 
eradicated during this screening period. No further cases of patients with MRSA 
were identified. This study suggests that, despite active screening of patients 
and adherence to strict infection control methods, MRSA cases continued to be 
identified. When MRSA was eradicated in the staff of the burn unit, the 
transmission of MRSA from employees to patients stopped and the outbreak 
ceased. 
It has been suggested that standard infection control practices routinely 
followed by hospital personnel are not sufficient to prevent the transmission of 
MRSA in the neonatal population. It is believed by many health officials and 
expert groups, such as the Society for Healthcare Epidemiology of America 
(SHEA), that additional measures, such as active surveillance of patients and 
staff, treatment with mupirocin of infected and colonized infants and staff and 
strict cohorting of infants and direct patient care staff, must be implemented in 
addition to conventional infection control practices when MRSA is identified, 
specifically in a NlCU setting. 
In response to the absence of accepted guidelines of routine infection 
control measures to contain and control MRSA in neonatal intensive care units, 
the Chicago Department of Public Health convened a working group to provide a 
consensus statement. The statement acknowledged that the neonatal population 
is particularly vulnerable to infections and colonization with MRSA. A survey of 
seven Chicago hospitals was conducted to identify the incidence of clusters of 
infants with MRSA infection or colonization in neonatal intensive care units. 
From June 2001 .through September 2002, 13 clusters were identified. 
Successful eradication of clusters of MRSA included interventions such as ,the 
cohorling of infants positive for MRSA and direct patient care staff, obtaining 
surveillance cultures of staff, and in five of the 13 clusters, both infants and 
health care workers were treated with mupirocin. 
We identified and controlled a common source outbreak of MRSA 
infection/colonization that involved 58 cases in 2002. The source of this outbreak 
appeared to be a single health care worker who was involved in the care of a 
majority of cases. When this health care worker was "treated" for MRSA nasal 
colonization and subsequently ider~Zified as negative for Staph colonization, and 
infection control recommendations were implemented, the outbreak was brought 
under control. 
Prior to this outbreak investigation, we believed that NlCU infants were "naturally" 
isolated because their environment was limited to isolettes. It was astounding for 
us to document the number of encounters by different employees that these 
infants had on a daily basis. We calculated approximately 75 encounters per 
infant per day. It was not uncommon for nlnrses to "cover" for each other, 
perhaps when one is taking a break or retrieving medications to administer. 
Whenever a nurse is working with a single infant in the NlCU and an event such 
as apnea occurs with another infant, there is no time for the nurse to complete 
her task, wash her hands and then tend to the distressed infant. During this type 
of emergency situation, the nurse proceeds directly to the other infant and 
conducts necessary actions. This type of activity usually requires direct patient 
contact and may increase the likelihood of transmitting organisms from one infant 
to another. While this situation may not be ideal, it is doubtful that anyone would 
criticize the nursing staff for emergently attending to the distressed infant. The 
use of physical "screens" established to separate MRSA positive infants and the 
staff caring for them from the rest of the patient population may truly have limited 
the progression of transmission of this pathogen. By cohorting staff specifically 
with ,the cases positive for MRSA, episodes of emergency interventions by 
"contaminated staff' were eliminated, therefore preventing transmission of MRSA 
on unwashed hands. 
It is not uncommon for employees involved in this situation to question 
standard activities that are carried out routinely. This type of scenario creates an 
atmosphere of stress and fear and adds to employee exhaustion. During the 
outbreak, the staff had grown exhausted and extremely concerned about their 
patients. 
A positive outcome from our investigation and control of this outbreak was 
a greater cohesiveness among the NlCU staff and a greater awareness of the 
need for consistent infection control practices. 
While review of infection control precautions implemented in caring for 
patients with epidemiologically significant organisms continues on an ongoing 
basis, policies and protocols have been developed as a result of this outbreak to 
aid in the effective and timely management of infants and mothers who are 
positive for MRSA. Some of these newly implemented interventions are as 
follows: 
Infants transported to the NlCU from other facilities or admitted from home are to have 
cultures of the nares and tracheal aspirate (if applicable) done upon admission. 
* "Rooming In" is encouraged if physically possible for all mothers and infants who are 
culture positive for MRSA. 
Mothers of infants with MRSA were allowed to perform "Kangaroo care" (breast 
feeding). In the case of twins, the non-colonized infant should be Kangarooed first. 
The mothers were asked to wash the chest area with a wash cloth and Basis soap after 
Kangaroo. 
Housekeepers should wear gowns and gloves when handling laundry and trash. 
It is acceptable for families of colonized infants to remove bottles for breast milk 
storage and their infant's laundry for cleaning at home. These should be placed in 
plastic bags for transport. 
Families and visitors will be reminded about the importance of hand washing after 
leaving the infant's bedside and before leaving the hospital. 
The bedsides of all infants (counters, pumps, other surfaces) will be wiped down at the 
beginning of each shift with hospital-approved disinfectant. 
Dietary Technicians are to wipe down the counter surface before and after making 
formula. 
If colonized infants leave the unit for transport to X-Ray or the OR, personnel of those 
areas are to be informed that infants are on SOAP isolation. This is a standardized 
infection control designation throughout the hospital. 
After the implementation of the above measures, the NlCU experienced the 
identification of few infants with cultures positive for MRSA and no further 
clusters or outbreaks of cases positive for MRSA. Routinely, standard measure 
of infection control practice is sufficient to prevent transmission of 
epidemiologically significant organisms. These include appropriate isolation 
precautions, effective hand hygiene and cohorting of patients and staff. It 
appears that especially during an outbreak situation, a successful measure to 
control transmission may be surveillance screening of patients and staff and 
judicious treatment of colonized individuals. 
V. Conclusion: 
As demonstrated through these investigations and the review of literature, MRSA 
and all multi-drug resistant organisms have evolved into a significant public 
health issue. The serious nature of the infections has been identified for many 
years. Hospitals have placed a great deal of resources in attempt to control the 
transrr~ission of these pathogens including infection control interventions. Over 
the past decade there has been a significant increase in the prevalence of 
community-acquired cases of MRSA infections and colonization. The changing 
trends in the epidemiology of this pathogen have posed a monumental challenge 
to health care facilities and public health institutions. It has become paramount 
to continue to control the transmission of this organism by increasing awareness 
of health care providers and the general population of good infection prevention 
and control practice. In addition to the control of transmission of this pathogen, 
there is increasing awareness that prevention of antibiotic resistance is equally 
important. The development of antibiotic stewardship programs recorr~mend 
judicious use of antibiotics and medically evidenced based accurate education. 
This public health problem has expanded beyond the confines of the hospitals, 
geographical borders and now has challenged public health entities globally. 
Prevention and control of this significant issue requires the collaborative effort of 
government, both local and federal, healthcare, public health, and the general 
population. 
APPENDIX A 
Glossary 
ARUP- A medical reference laboratory located in Salt Lake City, Utah that 
provides services for specialized laboratory testing. The Department of 
Laboratory Medicine at Hospital A utilizes this laboratory for tests that are 
currently not performed in the hospital laboratory. 
p- lactam antibiotics - Antibiotics that share a common structure known as the 
beta - lactam ring which is a structure composed of three carbon and one 
nitrogen molecules. This ring inhibits the synthesis of the bacterial cell wall, thus 
destroying the further formation of susceptible bacteria. Penicillins and 
cephalosporin antibiotics have f3- lactam rings. 
Colonization- Bacteria residing and multiplying in the GI tract, upper respiratory 
tract, skin, etc. without causing signs or symptoms of infection. These orgar~isms 
may become resistant to commor~ly prescribed antibiotics and may subsequerltly 
cause infections in the patient or be transferred to other patients, usually via the 
hands of health care providers. 
Communitv-acquired- Infection or colo~iization is defined as "community- 
acquired" if a causative organismlpathogen is cultured from that site within 48 
hours of admission to a hospital. The rationale for this time frame is that the 
incubation period of the majority of bacterial infections is 12 to 48 hours. 
Extended Care Facilitv- A facility in which there is a population of patients or 
clients maintained in general living conditions with separate or shared rooms. 
These include, but are not limited to, skilled nursing homes, assisted living 
facilities, rehabilitation facilities, veteran affair facilities and prisons. 
Hospital A- is a 234-bed acute-care teaching hospital in the Farmington Valley 
with approximately 10,000 discharges in 2005. It offers a full spectrum of clinical 
services in addition to specialty centers and a full set of diagnostic and 
therapeutic services such as invasive cardiac procedures. There are the 
following inpatient units: Neonatal Intensive Care unit, Labor and Delivery, 
Obstetric and Gynecological Unit, Emergency Department, Adult lntensive Care 
Unit, Cardiac Step-Down Unit, Psychiatric Unit, Geriatric Psychiatric Unit, 
Medicine Unit, Medical Department of Corrections Unit, Medical Oncology Unit, 
and a Surgical Unit that offers specialty care in Orthopedics, Urology, 
Neurosurgery, and Cardiovascular services. 
Hospital-acquired- Infections and/or colonization involving any body site identified 
in a patient who has been hospitalized more than 48 hours 
that was not present on admission. Infection- The diagnosis of infection implies a 
clinically significant event. The criteria for infection with any staphylococcal 
isolate includes the physician's documentation of the diagnosis of infection and 
may or may not have the additional criteria such as; classic signs of inflammation 
(redness, induration, warmth, swelling, pus, pain), antibiotic treatment, or the 
documentation of symptoms indicative of infection e.g., fever. 
International Classification of Diseases (ICD) 9 codes- these are numbers 
applied to conditions of morbidity and mortality issued by the World Health 
Organization to create a system for international comparability of illnesses. 
These codes can be used for statistical data and also for reimbursement 
purposes in the clinical setting. 
Isolate- reflects the recovery of bacteria from clinical specimens by the 
microbiology laboratory at Hospital A. The laboratory uses standard techniques 
to identify organisms, characterize them according to species, and identify their 
sensitivity andlor resistance to specific antibiotics. 
Line listinq - A tool used in Epidemiology to assist the practitioner in analyzing 
compiled patient-specific data in terms of person, place and time. 
Methicillin-resistant Sta~hv/ococcal aureus - (MRSA) A Staphylococcal aureus 
organism that is not sensitive to p-lactam antibiotics. These bacteria can continue 
to multiply in the presence of penicillin and cephalosporin and can either colonize 
or cause infection in susceptible hosts. 
Methicillin-sensitive Staphvlococcal aureus - (MSSA) An organism identified as 
Staphylococcal aureus that is sensitive to f3-lactam antibiotics and can either 
colorrize or infect patients. The growth of these bacteria is inhibited in the 
presence of virtually all penicillins and cephalosporins. 
Minimum Inhibitow Concentration - (MIC) is the least concentration of antibiotic 
that prevents an organism from growing in that environment. This result 
indicates the relative sensitivity or resistance of that isolate to a specific 
antibiotic. 
Pulse-Field Gel Electrophoresis - A technique used in the laboratory to separate 
long strands of DNA of a specimen in order to identify a fingerprint or a pattern of 
a specific organism in order to compare it with the fingerprint of other 
epidemiology-related organisms. 
Sites of Infection- The most cornmon body locations of infections are the urinary 
tract (related to use of indwelling urinary catheters), surgical sites (wounds), skin, 
lungs (pneumonias, often ventilator associated pneumonias in patients 
hospitalized in the ICU) and blood stream (in particular central line intravenous 
catheter - associated infections). 
Staphylococcus aureus- A ubiquitous organism that can colonize or infect 
patients. It is commonly cultured as a colonizer of the anterior nares. This 
organism is a common cause of skin and wound infections and can sometimes 
cause fatal cases of pneumonia or blood stream infections in very sick patients. 
It is also responsible for hospital-acquired infections, including pneumonias, 
serious wound infections and blood stream infections. 
Appendix B 
List of Abbreviations 
ARUP 
CSDU 
DOC 
ECF 
ED 
ICU 
MIC 
Med-4 
MedISurg 5 
MRSA 
MSSA 
NlCU 
OBIGYN 
Onc-6 
Psych 1 
Psych 3 
S. aureus 
Surg-7 
Associated Regional and University Pathologists, Inc. 
Cardiac Step-Down Unit 
Department of Corrections unit 
Extended Care Facility 
Emergency Department 
Adult Intensive Care Unit 
Minimum Inhibitory Concentration 
Medicine-4 Unit 
DOC Prison Unit 
Methicillin-resistant Staphylococcus aureus 
Methicillin-sensitive Staphylococcus aureus 
Neonatal Intensive Care Unit 
Obstetrical and Gynecological Unit 
Oncology-6 Unit 
Psychiatry Nursing Unit 
Geriatric Psychiatric Unit 
Staphylococcus aureus 
Surgery-7 Unit 
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